Tag: Eris Lifesciences
Biocon reports 30% revenue increase and ₹660 crore net profit in...
Biocon's Q1FY25 performance sees 117% EBITDA growth and ₹660 crore net profit, powered by strategic partnerships and biosimilar success
Eris Lifesciences reports 54% revenue growth in Q1 FY25
The company sees growth and synergy from recent acquisitions, with plans for further expansion in specialty and super-specialty segments
Nimotuzumab boosts survival rates in head & neck cancer: Tata Memorial...
Phase III study shows significant improvement in 10-year survival rates with Nimotuzumab addition, offering new hope for patients